EphA4‐KO tumor‐bearing mice without IGF1 administration showed a significant reduction in G‐CSF circulation level, which was enhanced by IGF1 treatment up to a level similar to that observed in WT tumor‐bearing mice (Fig. 6B). This evidence concerns the gene IGF1 and neoplasm.